Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001211583-07-000049
Filing Date
2007-05-07
Accepted
2007-05-07 12:19:51
Documents
2
Period of Report
2007-04-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc.html 3  
1 PRIMARY DOCUMENT doc.xml 3 5024
2 POWER OF ATTORNEY LETTER powerofattorney.txt EX-24 3108
  Complete submission text file 0001211583-07-000049.txt   9924
Mailing Address 4620 CREEKSTONE DRIVE SUITE 200 DURHAM NC 27703
Business Address 4620 CREEKSTONE DRIVE SUITE 200 DURHAM NC 27703 919-484-8484
ADHEREX TECHNOLOGIES INC (Issuer) CIK: 0001211583 (see all company filings)

EIN.: 000000000
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 623 FIFTH AVENUE SUITE 2503 NEW YORK NY 10022
Business Address 212.692.6349
Butts Robert W (Reporting) CIK: 0001378433 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32295 | Film No.: 07822966